Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07845617
Recruiting
Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
Not applicable · United States · 1 site
Registry update: 29 Sept 2026
NCT07501078
Recruiting
Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
Phase 2 · United States · 1 site
Registry update: 2 Nov 2026
NCT07413744
Recruiting
The Gut - PRO Study
Phase 1 · United States · 1 site
Registry update: 30 Oct 2026
NCT07795554
Recruiting
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Not applicable · China · 1 site
Registry update: 27 Oct 2026
NCT07401771
Recruiting
Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
Not applicable · United States · 1 site
Registry update: 20 Aug 2026
NCT07885319
Recruiting
Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma
Phase 1/2 · China · 3 sites
Registry update: 2 Nov 2026
NCT07909148
Recruiting
Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life
Not applicable · Sweden · 1 site
Registry update: 2 Nov 2026
NCT07557056
Recruiting
Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2 · United States · 1 site
Registry update: 15 Oct 2026
NCT07892027
Recruiting
Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy
Phase 2 · United States · 1 site
Registry update: 23 Oct 2026
NCT07281924
Recruiting
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Phase 1/2 · United States · 1 site
Registry update: 30 Oct 2026
NCT07674277
Recruiting
Virtual Reality for SCD VOC
Not applicable · United States · 1 site
Registry update: 16 Oct 2026
NCT07282210
Recruiting
Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype
Phase 2 · Canada · 4 sites
Registry update: 2 Nov 2026
NCT06752356
Recruiting
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 3 · United States · 6 sites
Registry update: 5 Nov 2026
NCT07917364
Recruiting
Asprosin and miRNA Expression in Young Women With Metabolic Syndrome
Not applicable · Poland · 1 site
Registry update: 4 Nov 2026
NCT07031219
Recruiting
HIV/HBV/HCV Triple Screening in Primary Care
Not applicable · United States · 1 site
Registry update: 29 Oct 2026
NCT07292298
Recruiting
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
Phase 2 · United States · 3 sites
Registry update: 2 Sept 2026
NCT07454707
Recruiting
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
Phase 3 · Canada · 1 site
Registry update: 23 Oct 2026
NCT07673744
Recruiting
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
Phase 2 · United States · 6 sites
Registry update: 29 Oct 2026
NCT07639606
Recruiting
Mobile Cognitive Behavioral Therapy in Early Stroke Recovery
Not applicable · United States · 1 site
Registry update: 23 Sept 2026
NCT06820723
Recruiting
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
Phase 2 · United States · 1 site
Registry update: 20 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.